Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcohol consumption increased the risk of prostate cancer: A Finnish pooled population-based cohort study.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Correction: Vitamin D status and type 2 diabetes incidence in Finnish adults-a longitudinal survey and register-based study using standardized serum 25-hydroxyvitamin D data.

European journal of nutrition·2026
Same author

Associations between pre-disease biomarkers of persistent organic pollutants and amyotrophic lateral sclerosis risk in four European cohorts.

Environmental research·2026
Same author

Mediation analysis in longitudinal intervention studies with an ordinal treatment-dependent confounder.

Statistical methods in medical research·2026
Same author

Examining the factor structure of the 40-item Defense Style Questionnaire among adults with depression: an individual participant data meta-analysis.

Research in psychotherapy (Milano)·2026
Same author

Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging.

JAMA internal medicine·2026

Related Experiment Video

Updated: May 12, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Confounding and missing data in cost-effectiveness analysis: comparing different methods.

Tommi Härkänen1, Timo Maljanen, Olavi Lindfors

  • 1National Institute of Health and Welfare, Mannerheimintie 166, P,O,Box 30, FIN-00271 Helsinki, Finland. tommi.harkanen@thl.fi.

Health Economics Review
|March 30, 2013
PubMed
Summary

Adjusting for confounders is crucial in cost-effectiveness analyses of nonrandomized studies. Bayesian inference effectively reveals unexplained cost-effectiveness associations and handles skewed cost data, improving analysis accuracy.

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Related Experiment Videos

Last Updated: May 12, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Health Economics
  • Statistical Modeling
  • Psychotherapy Research

Background:

  • Standard cost-effectiveness analyses (CEAs) often neglect confounders, leading to biased results in nonrandomized studies.
  • Parametric models face challenges with skewed cost distributions, zero costs, and unexplained cost-effectiveness associations.
  • Longitudinal data in CEAs present issues with missing observations, particularly for cumulative outcomes.

Purpose of the Study:

  • To compare methods for adjusting confounders in CEA using longitudinal data.
  • To evaluate the performance of generalized linear models and Bayesian inference in handling complex cost and effectiveness data.
  • To assess cost-effectiveness in the Helsinki Psychotherapy Study, considering Global Severity Index (SCL-90-GSI) and direct costs.

Main Methods:

  • Comparison of unadjusted bootstrap, generalized linear models with multiple imputation, and Bayesian hierarchical models.
  • Application to five repeated measurements of SCL-90-GSI and direct costs in two Defence Style Questionnaire (DSQ) groups.
  • Utilized hierarchical two-part logistic and gamma regression for costs, and hierarchical linear models for effectiveness.

Main Results:

  • Confounder adjustment reduced differences between DSQ groups.
  • Bayesian inference identified unexplained associations between costs and effectiveness.
  • Strong heteroscedasticity was observed in positive costs, indicating variability in cost-effectiveness.

Conclusions:

  • Accounting for confounders is essential in CEAs for nonrandomized comparative groups.
  • Bayesian methods offer a robust approach for complex cost-effectiveness data, including unexplained associations and heteroscedasticity.
  • Accurate CEA requires advanced statistical techniques to address data complexities.